Monday, 18 November 2019

Bristol-Myers teams up with Harvard researchers in fibrotic diseases

12 April 2018 | News

Under the terms of the agreement, Harvard academic researchers will collaborate with BMY scientists on four projects over three years.

Singapore - Bristol-Myers Squibb enters into a research collaboration with Harvard Stem Cell Institute's Harvard Fibrosis Network, a group of researchers across the schools and affiliated hospitals of Harvard University, to discover and develop new treatments for fibrotic diseases, including the liver and heart.

Under the terms of the agreement, Harvard academic researchers will collaborate with BMY scientists on four projects over three years.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account